XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
At-the-Market Equity Offerings (Tables)
 12 Months Ended
Dec. 31, 2023
At Market Equity Offerings [Abstract]  
Summary of Active At-the-Market Equity Offering The following table summarizes the terms and provisions of each sales agreement, and sales activity pursuant to each at-the-market equity offering program that was active during 2023, 2022, or 2021. The maximum aggregate offering price and net proceeds (less sales commissions and expenses) for each at-the-market equity offering program in the following table are reported in thousands.

 

 

 

November 2023 Sales Agreement

 

 

August 2023 Sales Agreement

 

 

May 2023 Sales Agreement

 

 

2022 Sales Agreement

 

 

2021 Sales Agreement

 

Agreement effective date

 

November 30, 2023

 

 

August 1, 2023

 

 

May 1, 2023

 

 

September 9, 2022

 

 

June 14, 2021

 

Sales agents

 

Cowen and Company, LLC, Canaccord Genuity LLC, and BTIG, LLC ("November 2023 Sales Agents")

 

 

Cowen and Company, LLC, Canaccord Genuity LLC, and Berenberg Capital Markets LLC ("August 2023 Sales Agents")

 

 

Cowen and Company, LLC and Canaccord Genuity LLC ("May 2023 Sales Agents")

 

 

Cowen and Company, LLC and BTIG, LLC ("2022 Sales Agents")

 

 

Jefferies, LLC ("2021 Sales Agents")

 

Maximum aggregate offering price

 

$

750,000

 

 

$

750,000

 

 

$

625,000

 

 

$

500,000

 

 

$

1,000,000

 

Maximum commissions payable to sales agents on gross proceeds from the sale of shares

 

 

2.0

%

 

 

2.0

%

 

 

2.0

%

 

 

2.0

%

 

 

2.0

%

Date terminated

 

n/a

 

 

November 29, 2023

 

 

August 1, 2023

 

 

May 1, 2023

 

 

December 28, 2021

 

Shares sold under such sales agreement during the year ended:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

 

1,076,915

 

 

 

1,592,950

 

 

 

1,079,170

 

 

 

1,348,855

 

 

n/a

 

December 31, 2022

 

n/a

 

 

n/a

 

 

n/a

 

 

 

218,575

 

 

n/a

 

December 31, 2021

 

n/a

 

 

n/a

 

 

n/a

 

 

n/a

 

 

 

1,413,767

 

Net proceeds received from shares sold under such sales agreement during the year ended:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

$

609,873

 

 

$

737,760

 

 

$

333,494

 

 

$

338,962

 

 

n/a

 

December 31, 2022

 

n/a

 

 

n/a

 

 

n/a

 

 

$

46,219

 

 

n/a

 

December 31, 2021

 

n/a

 

 

n/a

 

 

n/a

 

 

n/a

 

 

$

990,463

 

As of December 31, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative shares sold under such sales agreement

 

 

1,076,915

 

 

 

1,592,950

 

 

 

1,079,170

 

 

 

1,567,430

 

 

 

1,413,767

 

Cumulative net proceeds received from shares sold under such sales agreement

 

$

609,873

 

 

$

737,760

 

 

$

333,494

 

 

$

385,181

 

 

$

990,463

 

Maximum aggregate offering price remaining under such sales agreement

 

$

137,765

 

 

n/a

 

 

n/a

 

 

n/a

 

 

n/a